Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response

瑞布替尼抑制慢性荨麻疹患者血清刺激的荨麻疹效应细胞，与 FcεR1 表达水平和奥马珠单抗临床反应无关